Company

Sanyou Biopharmaceuticals Completes Series C Financing of Nearly RMB 100 Million – Zero2IPO Industry Investment Fund Backs AI‑Driven Drug Discovery Platform
FinanceSanyou Biopharmaceuticals

Sanyou Biopharmaceuticals Completes Series C Financing of Nearly RMB 100 Million – Zero2IPO Industry Investment Fund Backs AI‑Driven Drug Discovery Platform

Sanyou Biopharmaceuticals Co., Ltd. ("Sanyou Bio") announced the completion of a Series C financing round of nearly RMB 100 million. The round was exclusively invested by the Zero2IPO Industry Investment…

Viatris Reports Stable Q3 2026 Results with Enhanced Profitability – Raises Full‑Year Guidance as Pacira BioSciences Acquisition Nears Completion

Viatris Reports Stable Q3 2026 Results with Enhanced Profitability – Raises Full‑Year Guidance as Pacira BioSciences Acquisition Nears Completion

Boehringer Ingelheim and Ruijin Hospital Launch "China Bronchiectasis Care Action" at CIIE – Advancing Standardized Diagnosis and Long‑Term Disease Management

Boehringer Ingelheim and Ruijin Hospital Launch “China Bronchiectasis Care Action” at CIIE – Advancing Standardized Diagnosis and Long‑Term Disease Management

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Contact US
Fosun Pharma's Tenapanor Approved in China for CKD Dialysis Patients
Fosun PharmaceuticalHKG: 2196

Fosun Pharma’s Tenapanor Approved in China for CKD Dialysis Patients

WuXi XDC Expands MOU with LigaChem to Advance Next-Gen ADC Development
ADC / XDCCRO / CMO / CDMO

WuXi XDC Expands MOU with LigaChem to Advance Next-Gen ADC Development

Kexing Biopharm and Bio-Sincerity Pharmaceutical Form Strategic Alliance
Bio-Sincerity Pharmaceutical TechnologyKexing Biopharm

Kexing Biopharm and Bio-Sincerity Pharmaceutical Form Strategic Alliance

Harbour BioMed Licenses HAT001/HBM9013 to Global Partner for CRH-Targeted Therapy
BiotechHarbour BioMed

Harbour BioMed Licenses HAT001/HBM9013 to Global Partner for CRH-Targeted Therapy

Show More